The prevalence of incidental gastric NETs in obesity surgery candidates was found to be high [26] and the occurrence of a pNET co-secreting GLP-1 and glucagon in a patient previously submitted for gastric bypass surgery was also reported [27]. The gene discussed is GCG; the disease is gastric neuroendocrine tumor, well differentiated, low or intermediate grade.